{
    "title": "115_s2920",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Commit to Opioid Medical Prescriber \nAccountability and Safety for Seniors Act of 2018''.\n\nSEC. 2. MEDICARE REQUIREMENTS WITH RESPECT TO OUTLIER PRESCRIBERS OF \n              OPIOIDS.\n\n    Section 1860D-4(c)(4) of the Social Security Act (42 U.S.C. 1395w-\n104(c)(4)) is amended by adding at the end the following new \nsubparagraph:\n                    ``(D) Notification and additional requirements with \n                respect to outlier prescribers of opioids.--\n                            ``(i) Notification.--Not later than January \n                        1, 2021, the Secretary shall, in the case of a \n                        prescriber identified by the Secretary under \n                        clause (ii) to be an outlier prescriber of \n                        opioids, provide, subject to clause (iv), an \n                        annual notification to such prescriber (during \n                        the period in which such provider maintains \n                        such identification) that such prescriber has \n                        been so identified and including such resources \n                        on proper prescribing methods and such other \n                        information as specified in accordance with \n                        clause (iii).\n                            ``(ii) Identification of outlier \n                        prescribers of opioids.--\n                                    ``(I) In general.--The Secretary \n                                shall, subject to subclause (III), \n                                using the valid prescriber National \n                                Provider Identifiers included pursuant \n                                to subparagraph (A) on claims for \n                                covered part D drugs for part D \n                                eligible individuals enrolled in \n                                prescription drug plans under this part \n                                and MA-PD plans under part C and based \n                                on the thresholds established under \n                                subclause (II), identify prescribers \n                                that are outlier opioids prescribers \n                                for a period of time specified by the \n                                Secretary.\n                                    ``(II) Establishment of \n                                thresholds.--For purposes of subclause \n                                (I) and subject to subclause (III), the \n                                Secretary shall, after consultation \n                                with stakeholders, establish \n                                thresholds, based on prescriber \n                                specialty and, as determined \n                                appropriate by the Secretary, \n                                geographic area, for identifying \n                                whether a prescriber in a specialty and \n                                geographic area is an outlier \n                                prescriber of opioids as compared to \n                                other prescribers of opioids within \n                                such specialty and area.\n                                    ``(III) Exclusions.--The following \n                                shall not be included in the process \n                                for identifying outlier prescribers of \n                                opioids under this clause:\n                                            ``(aa) Claims for covered \n                                        part D drugs for part D \n                                        eligible individuals who are \n                                        receiving hospice care under \n                                        this title.\n                                            ``(bb) Claims for covered \n                                        part D drugs for part D \n                                        eligible individuals who are \n                                        receiving oncology services \n                                        under this title.\n                                            ``(cc) Prescribers who are \n                                        the subject of an investigation \n                                        by the Centers for Medicare & \n                                        Medicaid Services or the Office \n                                        of the Inspector General of the \n                                        Department of Health and Human \n                                        Services.\n                            ``(iii) Contents of notification.--The \n                        Secretary shall include the following \n                        information in the notifications provided under \n                        clause (i):\n                                    ``(I) Information on how such \n                                prescriber compares to other \n                                prescribers within the same specialty \n                                and, if determined appropriate by the \n                                Secretary, geographic area.\n                                    ``(II) Information on opioid \n                                prescribing guidelines, based on input \n                                from stakeholders, that may include the \n                                Centers for Disease Control and \n                                Prevention guidelines for prescribing \n                                opioids for chronic pain and guidelines \n                                developed by physician organizations.\n                                    ``(III) Other information \n                                determined appropriate by the \n                                Secretary.\n                            ``(iv) Modifications and expansions.--\n                                    ``(I) Frequency.--Beginning 5 years \n                                after the date of the enactment of this \n                                subparagraph, the Secretary may change \n                                the frequency of the notifications \n                                described in clause (i) based on \n                                stakeholder input and changes in opioid \n                                prescribing utilization and trends.\n                                    ``(II) Expansion to other \n                                prescriptions.--The Secretary may \n                                expand notifications under this \n                                subparagraph to include identifications \n                                and notifications with respect to \n                                concurrent prescriptions of covered \n                                part D drugs used in combination with \n                                opioids that are considered to have \n                                adverse side effects when so used in \n                                such combination.\n                            ``(v) Additional requirements for \n                        persistent outlier prescribers.--In the case of \n                        a prescriber who the Secretary determines is \n                        persistently identified under clause (ii) as an \n                        outlier prescriber of opioids, the following \n                        shall apply:\n                                    ``(I) The Secretary shall connect \n                                such prescriber with an entity that \n                                provides technical or educational \n                                resources on opioid prescribing \n                                guidelines (such as the guidelines \n                                described in clause (iii)(II)), which \n                                may include a quality improvement \n                                organization under part B of title XI, \n                                as available and appropriate.\n                                    ``(II) Such prescriber may be \n                                required to enroll in the program under \n                                this title under section 1866(j) if \n                                such prescriber is not otherwise \n                                required to enroll. The Secretary shall \n                                determine the length of the period for \n                                which such prescriber is required to \n                                maintain such enrollment.\n                                    ``(III) Not less frequently than \n                                annually (and in a form and manner \n                                determined appropriate by the \n                                Secretary), the Secretary shall \n                                communicate information on such \n                                prescribers to sponsors of a \n                                prescription drug plan and Medicare \n                                Advantage organizations offering an MA-\n                                PD plan.\n                            ``(vi) Public availability of \n                        information.--The Secretary shall make \n                        aggregate information under this subparagraph \n                        available on the Internet website of the \n                        Centers for Medicare & Medicaid Services. Such \n                        information shall be in a form and manner \n                        determined appropriate by the Secretary and \n                        shall not identify any specific prescriber. In \n                        carrying out this clause, the Secretary shall \n                        consult with interested stakeholders.\n                            ``(vii) Opioids defined.--For purposes of \n                        this subparagraph, the term `opioids' has such \n                        meaning as specified by the Secretary.\n                            ``(viii) Other activities.--Nothing in this \n                        subparagraph shall preclude the Secretary from \n                        conducting activities that provide prescribers \n                        with information as to how they compare to \n                        other prescribers that are in addition to the \n                        activities under this subparagraph, including \n                        activities that were being conducted as of the \n                        date of the enactment of this subparagraph.''."
}